[NBIX] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
01-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 49.77%
YoY- -31.94%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 590,200 452,700 378,200 288,900 302,400 183,580 96,905 35.10%
PBT 98,600 121,600 -23,300 57,500 83,200 52,091 -5,913 -
Tax 33,600 26,100 -6,400 15,200 3,600 753 7,591 28.10%
NP 65,000 95,500 -16,900 42,300 79,600 51,338 -5,913 -
Tax Rate -34.08% -21.46% - -26.43% -4.33% -1.45% - -
Total Cost 525,200 357,200 395,100 246,600 222,800 132,242 102,818 31.20%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 11.01 21.10 -4.47 14.64 26.32 27.96 -6.10 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.64 0.98 -0.18 0.45 0.86 0.56 -0.07 -
EPS Diluted 0.63 0.95 -0.18 0.43 0.81 0.54 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.